Trial Profile
A phase I, first-in-human study of BIT 225 in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Aug 2009
Price :
$35
*
At a glance
- Drugs BIT 225 (Primary)
- Indications Hepatitis C; HIV infections
- Focus Adverse reactions
- 06 Aug 2009 New trial record.